Back to top
more

QUIDELORTHO CP (QDEL)

(Delayed Data from NSDQ)

$103.45 USD

103.45
1,844,305

+3.85 (3.87%)

Updated May 27, 2022 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.08%
2Buy18.56%
3Hold10.15%
4Sell5.79%
5Strong Sell2.83%
S&P50011.24%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (172 out of 253)

Industry: Medical - Products

Trades from $1

Company Summary

San Diego, CA-based Quidel Corporation is a key player in the development, manufacturing and marketing of rapid diagnostic testing solutions. These solutions are separated into four product categories. The company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent-care clinics, leading universities, retail clinics, pharmacies and wellness screening centers. Quidel operates in one business segment that develops, manufactures and markets its four product categories.

Product Categories

Rapid Immunoassay (70.5% of aggregate revenues in FY 2021, up 4.6% ...

General Information

QuidelOrtho Corp

9975 SUMMERS RIDGE ROAD

SAN DIEGO, CA 92121

Phone: 858-552-1100

Fax: 858-453-4338

Web: http://www.quidel.com

Email: rargueta@quidel.com

Industry Medical - Products
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2022
Exp Earnings Date

This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

8/4/2022

EPS Information

Current Quarter EPS Consensus Estimate 3.38
Current Year EPS Consensus Estimate 16.78
Estimated Long-Term EPS Growth Rate NA
Exp Earnings Date

This is an estimated date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

8/4/2022

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 99.60
52 Week High 180.06
52 Week Low 88.05
Beta 0.02
20 Day Moving Average 665,068.75
Target Price Consensus 177.50

QDEL

% Price Change
4 Week 2.45
12 Week 2.22
YTD -23.36
% Price Change Relative to S&P 500
4 Week 5.63
12 Week 7.27
YTD -13.34
Share Information
Shares Outstanding (millions) 41.85
Market Capitalization (millions) 4,329.18
Short Ratio NA
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 6.17
Trailing 12 Months 4.13
PEG Ratio NA
EPS Growth
vs. Previous Year 170.02%
vs. Previous Quarter 60.81%
   
Sales Growth
vs. Previous Year 167.03%
vs. Previous Quarter 57.37%
   
Price Ratios
Price/Book 1.79
Price/Cash Flow 5.39
Price / Sales 1.86
ROE
3/31/22 56.46
12/31/21 45.78
9/30/21 62.24
ROA
3/31/22 44.21
12/31/21 35.06
9/30/21 46.33
Current Ratio
3/31/22 4.29
12/31/21 4.45
9/30/21 3.87
Quick Ratio
3/31/22 3.92
12/31/21 3.84
9/30/21 3.20
Operating Margin
3/31/22 44.85
12/31/21 43.56
9/30/21 48.80
Net Margin
3/31/22 43.26
12/31/21 41.46
9/30/21 47.20
Pre-Tax Margin
3/31/22 55.87
12/31/21 53.01
9/30/21 60.96
Book Value
3/31/22 57.71
12/31/21 46.30
9/30/21 39.21
Inventory Turnover
3/31/22 3.10
12/31/21 2.17
9/30/21 2.20
Debt-to-Equity
3/31/22 0.00
12/31/21 0.00
9/30/21 0.00
Debt to Capital
3/31/22 0.00
12/31/21 0.00
9/30/21 0.00